Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Forethought Consulting

With exceptional honest advice and counsel to enable the development of your public affairs strategies. Projects are neither too small nor too large. We can provide the necessary expertise from monitoring and analysis of a situation through to the development and implementation of a public affairs programme to support your business goals.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Health policy and government affairs, Market access, Market research

Company Details

Forethought Consulting
11 Maybury Mews, London, N6 5YT, United Kingdom
+44 (0)20 8340 3258
Contact Forethought Consulting
Website

 Latest Content from PMHub 

Fox&Cat Now Helps All Communications Teams To Thrive Under Pressure

Press Releases | May 31, 2022 | Fox&Cat

Specialist communications agency fox&cat relaunches today with a refined proposition: to help all communications teams thrive under pressure.  So, whether pressure is being felt in an in-house team, an agency, or...

Using ethnography to uncover the authentic patient experience

Press Releases | May 27, 2022 | Origins – The Patient Focused Specialists

Ahead of their webinar on 7th June ‘Revealing the true patient experience through ethnography’, Su Smith, Director of Origins Insights, looks at the benefits of ethnography from a patient and...

11 London: first UK healthcare agency to be awarded B Corp status

Press Releases | May 27, 2022 | 11 London

This month – May 2022 – 11 London was awarded B Corp status.

Improving Drug Access with Data Analytics

Videos and Podcasts | May 26, 2022 | Impetus Digital

Earlene Biggs, VP of Market Research & Analytics at ICON, explores best practices for life science market research and actionable analytics. She also shares her tips for creating organizational wellbeing...

How digital health is changing the relationship between patients and health providers | OPEN Health

Press Releases | May 26, 2022 | OPEN Health

The pandemic has forced pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes

How ‘Greenwashing’ accusations could delay the very changes its supporters demand

White Papers and Resources | May 26, 2022 | Say Communications

Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...

A Medscape Oncology exclusive preview

Press Releases | May 25, 2022 | Medscape Education

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. We are the largest medical education provider, delivering precision education for actionable outcomes across 30+ specialties in...

What does the future hold for clinical trial recruitment?

White Papers and Resources | May 25, 2022 | Page & Page Health

The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...

Part 1 of the Medscape video interview series

Videos and Podcasts | May 24, 2022 | Medscape Education

Ahead of  Europe’s largest hematology conference Hansa Bhargava MD, Medscape Education Chief Medical Officer, interviews Dr Loretta Nastoupil on the most important abstracts to look out for at EHA in lymphoma...

Medscape: Connect to the conversation

Press Releases | May 20, 2022 | Medscape Education

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. We are the largest medical education provider, delivering precision education for actionable outcomes across 30+ specialties in...